Oppenheimer analyst Michael Wiederhorn maintained a Hold rating on Enhabit, Inc (EHAB – Research Report) today. The company’s shares closed yesterday at $7.86.
Wiederhorn covers the Healthcare sector, focusing on stocks such as Centene, Community Health, and HCA Healthcare. According to TipRanks, Wiederhorn has an average return of 15.5% and a 68.07% success rate on recommended stocks.
Currently, the analyst consensus on Enhabit, Inc is a Hold with an average price target of $10.63, implying a 35.24% upside from current levels. In a report released today, TD Cowen also assigned a Hold rating to the stock with a $12.00 price target.
See today’s best-performing stocks on TipRanks >>
EHAB market cap is currently $394M and has a P/E ratio of -4.86.
Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EHAB in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Enhabit, Inc (EHAB) Company Description:
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health agencies provide a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services.
Read More on EHAB:
